| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ZM-447439 | GDSC1000 | pan-cancer | AAC | 0.097 | 0.009 |
| mRNA | ML311 | CTRPv2 | pan-cancer | AAC | 0.088 | 0.009 |
| mRNA | AZD8055 | GDSC1000 | pan-cancer | AAC | 0.088 | 0.01 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | 0.083 | 0.01 |
| mRNA | CEP-701 | FIMM | pan-cancer | AAC | -0.33 | 0.01 |
| mRNA | BRD-K97651142 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.01 |
| mRNA | Cisplatin | GDSC1000 | pan-cancer | AAC | 0.089 | 0.01 |
| mRNA | phloretin | CTRPv2 | pan-cancer | AAC | 0.091 | 0.01 |
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | 0.14 | 0.01 |
| mRNA | docetaxel:tanespimycin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.086 | 0.01 |